Compare Amphastar Pharmaceuticals Inc (AMPH) vs Walmart Stores Inc (WMT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Walmart Stores Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Walmart Stores Inc trades at $114.11 (market cap $906.43B). The key difference: Walmart Stores Inc is far larger — about 1097.3× Amphastar Pharmaceuticals Inc's market cap, and Walmart Stores Inc pays a 0.87% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | WMT | |
|---|---|---|
Market Cap | $826.08M | $906.43B |
Sector | Health | Consumer Staples |
52-Week High | $30.81 | $134.20 |
52-Week Low | $16.87 | $94.40 |
Enterprise Value | $1.22B | $969.88B |
Volume | — | 5,675,288 |
Dividend Yield | — | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Walmart (WMT) trades at $113.9, up 1.51% today, amid mixed signals. The stock shows bearish technical indicators but strong fundamentals with consistent earnings beats and revenue growth to $681.0 billion in 2025. Recent news highlights Walmart's AI initiatives and philanthropic efforts, while competition intensifies as Amazon surpasses it in Fortune 500 revenue ranking.
The outlook remains positive with a consensus price target of $141.64, implying significant upside. Risks include competitive pressures and economic sensitivity, but Walmart's scale, dividend stability, and operational efficiency support a bullish long-term view for investors seeking defensive growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Walmart Stores Inc
Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →
